The global single cell analysis market size is expected to reach USD 5.9 billion by 2025

It is projected to expand at a CAGR of 17.3% during the forecast period. High demand for early detection techniques and rapid technological advancements are creating a significant demand for single cell analysis. This technique is used in genomic, transcriptomic, proteomics, and epigenetic studies.

Single cell analytics helps assess cellular heterogeneity and aids in analysis of pathways and processes at a molecular level. It can be performed with samples as small as a single cell. Its current applications in diagnostics include genetic analysis, prenatal screening, cancer genomics, and neurological therapeutics.

Rising prevalence of chronic diseases is anticipated to drive demand for molecular assay services, subsequently leading to the growth of this sector. Single cell analysis plays an important role in risk management related to organ transplants, cancer, heart failure, renal diseases, and infectious disease testing by performing fast, accurate, and effective tests.

Further key findings from the study suggest:

In 2016, consumables accounted for the largest market share owing to rapid adoption of beads and microplates, repeat purchase of reagents, and demand for assay kits

Automated instruments lead the instruments segment, owing to their advantages over manually operated variants

Companies in this market are implementing strategies such as mergers and acquisitions to expand their product portfolio and to strengthen their position. The partnership between Illumina, Inc. and Bio-Rad Laboratories, Inc. is an example of strategies implemented by leading players